Insights from 2023 ESMO Annual Meeting
A

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -03 Clinical Trials - Advanced Extrahepatic Cholangiocarcinoma"

By Insights from 2023 ESMO Annual Meeting FEATURING Angela Lamarca
By Insights from 2023 ESMO Annual Meeting FEATURING Angela Lamarca
0 views
October 26, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Recommended

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
22:33
Integrity CE

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow
28:25
Integrity CE

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
25:09
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC…

Feat. R. Kim, T. Biachi
09:13
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary C…

Feat. N. Uboha, K. Spencer, M. Cecchini
12:04
Arndt Vogel

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
11:27
Integrity Continuing Education

Hepatic Arterial Infusion for Primary Liver Cancer

Feat. K. Lafaro
21:46
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…

Feat. M. Ikeda
15:49
Integrity CE

Updates in Targeted Therapies for Metastatic Biliary Tract Cancers

Feat. J. Harding
04:39
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor …

Feat. G. Abou-Alfa
12:21
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…

Feat. M. Yarchoan
13:45
Flavio Rocha

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

31:47
UChicago Medicine

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing…

Feat. A. A. Pillai
05:46
Penn Medicine Abramson Cancer Center

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Feat. T. Karasic
09:05
AACR 2023 Conference Coverage

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

Feat. K. Kelley
06:51
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

Feat. A. Vogel
25:14
Houston Methodist Hospital

Cholangiocarcinoma Updates

Feat. M. Javle
10:43
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Clas…

Feat. A. Vogel